Free AI web copilot to create summaries, insights and extended knowledge, download it at here

Abstract

r vascular and heart valve. $7B mid cap. Calcium problems with blood vessels. Continued coronary growth for new accounts and better penetrate existing. Accelerated peripheral growth due to combination of upcoming launch of M5 plus catheter and improved peripheral reimbursement for above the knee codes. Continued strengthening of international business in France UK. International sales to 11 countries.</p><p id="21b2"><b>Artivion Inc</b>. AORT for implantable devices for surgery.$ 1B for small cap. Heart valves and grafts. Surgical Sealant. three core technology areas, left heart access, mapping and therapy guidance, and therapy. AcQBlate for mapping for cardiac arrhythmias for FBA approval in 2023.</p><p id="10da"><b>Muscle bone related</b>.</p><p id="e5ce"><b>CONMED</b>. CNMD for minimally invasive orthopedic surgery. $5B mid cap. Various products for orthopedics. Various products for laparoscopic robotic open surgery. Various products for gastroenterology and pulmonology. 8.4% increase in sales year over year.</p><p id="1e4a"><b>Cutera Inc</b>. CUTR for laser aesthetics muscle.$ 1B small cap. Sculpting. Skin. Pigmentation. Lesions. Hair. Tattoo. Key Account Managers. Customer centric sales strategy. Capital equipment sales is a key driver. Robust consumable growth. Innovative energy based solution for acne. 31% growth in quarterly revenues. Cost saving measures for logistics.</p><p id="e90b"><b>Establishment Labs Holdings</b>. ESTA for plastic surgery. $2B small cap. Silicone implants. 31% fourth quarter growth. 2 million Motiva implants. 45% softer and 23% more adaptable. Joy program in Europe. Soon Mia program to be launched. Women’s Choice program for free removal.</p><p id="249d"><b>Globus Medical Inc</b>. GMED for musculoskeletal implants.$ 7B mid cap. Spine. Ankle. Clavicle. Wrist. Tibia. Mini Fragment. Humerus. 22% higher revenue for the quarter. Top 10 spine companies in the world. Robotic utilization, cases per robot was at an all time high. 9% international growth. New launch of Excelsius 3D for robotics, imaging, freehand navigation.</p><p id="c6f2"><b>Nuvasive Inc</b>. NUVA for spine surgery. $3B mid cap. Spine. Multiple products for replacement. 8.4% increase in sales. International growth in double digit. US Spinal hardware division. US surgical support business. Leadership position in less invasive surgery. Integrated solutions to treat any patient pathology with any procedural offering. Pulse is an integrated technology platform. Enabling tech.</p><p id="770d"><b>PROCEPT BioRobotics Corp</b>. PRCT for surgical robotics.$ 2B small cap. Aquablation for BPH. Robotic Technology. 350% increase in revenue. 3 revenue divisions: US AquaBeam system, US hand piece and consumable, international. Aquablation’s superior safety and superior symptom relief.</p><p id="b0c9">

Options

<b>Paragon 28</b>. FNA for foot and ankle systems. $1.5B small cap. For foot and ankle. Multiple products and systems. 28 bones in foot. Approval for 3 new products. smart 28 for anatomy surgical modules. Disior acquisition for software for modeling and planning. 8 products launched in 2021. 22% growth year over year. Increase in sales force.</p><p id="9266"><b>ZimVie Inc</b>. ZIMV for dental and spine. Recent IPO.$ 700M small cap. Spine and cervical. Allografts and biologics. This is a recent IPO company. Implants, surgical tools, bone grafts.</p><p id="d2f1"><b>Stryker Corp</b>. SYK for bones brain spine. $100B large cap. Very large company. Orthopedics. Neuro technology. Services side.</p><p id="eb9c"><b>Nervous system</b>.</p><p id="1faf"><b>Inspire Medical Systems Inc</b>. INSP for sleep apnea.$ 7B mid cap. Sleep products. Spun out of Medtronic.</p><p id="d2a8"><b>Natus Medical</b>. NTUS for nervous sensory newborns. $1B small cap. Neuro diagnostic and monitoring solutions including EEG, LTM, ICU, PSG, EMG, EP, IOM and obstetric and vascular handheld Doppler.</p><p id="dca4"><b>Summary</b>.</p><p id="e8ef">Out of various sectors, healthcare sector has less risk. Out of the various industries in healthcare, medical devices is more technical, more competitive, less commodity products services.</p><p id="7aa1">Within medical devices industry there are various themes for companies. Analysis and Diagnostics. Blood Sugar and Bladder. Cardio and Vascular. Joints, Knees, Spine. Muscles, Skin, Cosmetics. Teeth and Dental. Sleep and Respiration. Neuro, Nervous System and Brain.</p><p id="68d5"><b>Watch List</b>. If someone is looking at Healthcare sector these stocks are trending. Potentially on a watch list. If there is a correction, the prices would be very competitive. In case the market rallies, some of these stocks could gain momentum.</p><p id="54ad"><b>Standard Disclaimer</b>. <b>My stories on Medium.com are distributed for general informational and educational purposes only and are not intended to constitute legal, tax, accounting or investment advice</b>. I am not a professional financial advisor, attorney or account, nor am I holding myself out to be.</p><p id="16c6"><b>References</b>.</p><div id="b7fd" class="link-block"> <a href="http://www.fool.com"> <div> <div> <h2>The Motley Fool</h2> <div><h3>If a Motley Fool Member held 25 or more stocks from our recommendations for at least 5 years, the likelihood that…</h3></div> <div><p>www.fool.com</p></div> </div> <div> <div style="background-image: url(https://miro.readmedium.com/v2/resize:fit:320/0*sE-gWLSh2rrPPW6Q)"></div> </div> </div> </a> </div></article></body>

Stock Market. Business. Technology. Crypto. Self Improvement. Life.

Trending HealthCare Stocks for Medical Devices in Downturn

Look at HealthCare sector stocks that are still trending reasonably well.

More on the technology side of healthcare.

US Medical Devices ETF

Medical Devices Industry Sector.

There are many large companies in this space.

Abbott Labs for pharmaceutical and diagnostics. Bio-Rad Labs for research and clinical diagnosis.

Medtronic for cardio, surgery, diabetes related. Edwards LifeSciences for cardio and surgery. Abiomed for heart pumps.

Stryker for bones spine neuro. Zimmer Biomet for spine face thorax. Smith & Nephew for knee hip joint implants.

Boston Scientific for surgery and neuro. Align Tech for dental alignment. Insulet for insulin.

Let us look at companies trending well in this space.

Axonics Inc. AXNX for bladder. $3B mid cap. Sacral neuro modulation. Bladder and bowel. New system approval. 53% increase in quarterly revenue. Sacral neuro modulation 28% increase year over year. Bulkamid bulking hydrogel for stress urinary incontinence increased 27%.

Iradimed Corp. IRMD for MRI IV infusion pumps tubing. $500M small cap. Next generation IV pump. Also monitor. 39% increase in quarterly revenues. Strong demand and growing backlog. Towards FDA approval for clearance of next gen IV pump. Technologically superior product of new ferromagnetic detector.

Blood vessel vascular and cardio related products.

Boston Scientific Corp BSX for surgery neuro cardiovascular. $65B large cap. Interventional Cardiology is the main. Huge company. Multiple product lines. Lots of acquisitions.

Edwards Lifesciences Corp. EW for heart and surgery. $70B large cap. FDA approval for our ALLIANCE pivotal trial for next gen TAVR, SAPIEN X4. A portfolio of pioneering therapies for patients. Positive pivotal trial results to support approvals and adoption. Favorable real world clinical outcomes. Leadership position in Surgical Structural Heart. 10% increase in TAVR sales for the quarter.

Inari Medical Inc. NARI for venous diseases. $5B mid cap. Growth drivers: expansion of sales organization. Scope for 2000 hospitals. Aware and adoption. Instead of anti coagulation. Base of clinical evidence. Expanding product portfolio. Expansion into international markets.

Shockwave Medical Inc. SWAV for vascular and heart valve. $7B mid cap. Calcium problems with blood vessels. Continued coronary growth for new accounts and better penetrate existing. Accelerated peripheral growth due to combination of upcoming launch of M5 plus catheter and improved peripheral reimbursement for above the knee codes. Continued strengthening of international business in France UK. International sales to 11 countries.

Artivion Inc. AORT for implantable devices for surgery. $1B for small cap. Heart valves and grafts. Surgical Sealant. three core technology areas, left heart access, mapping and therapy guidance, and therapy. AcQBlate for mapping for cardiac arrhythmias for FBA approval in 2023.

Muscle bone related.

CONMED. CNMD for minimally invasive orthopedic surgery. $5B mid cap. Various products for orthopedics. Various products for laparoscopic robotic open surgery. Various products for gastroenterology and pulmonology. 8.4% increase in sales year over year.

Cutera Inc. CUTR for laser aesthetics muscle. $1B small cap. Sculpting. Skin. Pigmentation. Lesions. Hair. Tattoo. Key Account Managers. Customer centric sales strategy. Capital equipment sales is a key driver. Robust consumable growth. Innovative energy based solution for acne. 31% growth in quarterly revenues. Cost saving measures for logistics.

Establishment Labs Holdings. ESTA for plastic surgery. $2B small cap. Silicone implants. 31% fourth quarter growth. 2 million Motiva implants. 45% softer and 23% more adaptable. Joy program in Europe. Soon Mia program to be launched. Women’s Choice program for free removal.

Globus Medical Inc. GMED for musculoskeletal implants. $7B mid cap. Spine. Ankle. Clavicle. Wrist. Tibia. Mini Fragment. Humerus. 22% higher revenue for the quarter. Top 10 spine companies in the world. Robotic utilization, cases per robot was at an all time high. 9% international growth. New launch of Excelsius 3D for robotics, imaging, freehand navigation.

Nuvasive Inc. NUVA for spine surgery. $3B mid cap. Spine. Multiple products for replacement. 8.4% increase in sales. International growth in double digit. US Spinal hardware division. US surgical support business. Leadership position in less invasive surgery. Integrated solutions to treat any patient pathology with any procedural offering. Pulse is an integrated technology platform. Enabling tech.

PROCEPT BioRobotics Corp. PRCT for surgical robotics. $2B small cap. Aquablation for BPH. Robotic Technology. 350% increase in revenue. 3 revenue divisions: US AquaBeam system, US hand piece and consumable, international. Aquablation’s superior safety and superior symptom relief.

Paragon 28. FNA for foot and ankle systems. $1.5B small cap. For foot and ankle. Multiple products and systems. 28 bones in foot. Approval for 3 new products. smart 28 for anatomy surgical modules. Disior acquisition for software for modeling and planning. 8 products launched in 2021. 22% growth year over year. Increase in sales force.

ZimVie Inc. ZIMV for dental and spine. Recent IPO. $700M small cap. Spine and cervical. Allografts and biologics. This is a recent IPO company. Implants, surgical tools, bone grafts.

Stryker Corp. SYK for bones brain spine. $100B large cap. Very large company. Orthopedics. Neuro technology. Services side.

Nervous system.

Inspire Medical Systems Inc. INSP for sleep apnea. $7B mid cap. Sleep products. Spun out of Medtronic.

Natus Medical. NTUS for nervous sensory newborns. $1B small cap. Neuro diagnostic and monitoring solutions including EEG, LTM, ICU, PSG, EMG, EP, IOM and obstetric and vascular handheld Doppler.

Summary.

Out of various sectors, healthcare sector has less risk. Out of the various industries in healthcare, medical devices is more technical, more competitive, less commodity products services.

Within medical devices industry there are various themes for companies. Analysis and Diagnostics. Blood Sugar and Bladder. Cardio and Vascular. Joints, Knees, Spine. Muscles, Skin, Cosmetics. Teeth and Dental. Sleep and Respiration. Neuro, Nervous System and Brain.

Watch List. If someone is looking at Healthcare sector these stocks are trending. Potentially on a watch list. If there is a correction, the prices would be very competitive. In case the market rallies, some of these stocks could gain momentum.

Standard Disclaimer. My stories on Medium.com are distributed for general informational and educational purposes only and are not intended to constitute legal, tax, accounting or investment advice. I am not a professional financial advisor, attorney or account, nor am I holding myself out to be.

References.